Development of a synthetic library of humanized nanobodies for targeted IL-6 inhibition
Interleukin-6 (IL-6) is a cytokine that can bind to IL-6 receptor and induce pleiotropic effects. It serves as a critical biomarker, involved in inflammation amplification, tumor progression, and many other disease developments. Nanobodies, featuring small structure and high affinity, are a powerful...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-07-01
|
| シリーズ: | Frontiers in Bioengineering and Biotechnology |
| 主題: | |
| オンライン･アクセス: | https://www.frontiersin.org/articles/10.3389/fbioe.2024.1440150/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|